Metraipolis › archive › dc_deb147fe1217

Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD-Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses — Europe PMC PMID:41441710

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41441710
DOI
10.3390/vaccines13121244
License (as archived)
solo-consultazione
Archived
2026-11-07T15:42:31.471Z
SHA-256 of the archived text
ee716cf2f520583789cacabee48590640b7780d167ab8b75e9a62bfc95ebb5f2
Stable URL of this page
https://metraipolis.com/documento/dc_deb147fe1217

How to cite

Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD-Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses — Europe PMC PMID:41441710 — Europe PMC (en), https://europepmc.org/article/MED/41441710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_deb147fe1217 (Metraipolis archive dc_deb147fe1217, sha256 ee716cf2f520583789cacabee48590640b7780d167ab8b75e9a62bfc95ebb5f2)
BibTeX
@misc{dcdeb147fe1217,
  title = {Integrated In Silico and In Vivo Evaluation of a Tetravalent SARS-CoV-2 RBD-Fc Fusion Vaccine with Broad Cross-Variant Antibody Responses — Europe PMC PMID:41441710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41441710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_deb147fe1217; sha256 ee716cf2f520583789cacabee48590640b7780d167ab8b75e9a62bfc95ebb5f2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41441710. Agents can read the archived copy with the MCP tool read_document.